August 21, 2014 1:08 AM ET

Healthcare Equipment and Supplies

Company Overview of Therasis, Inc.

Company Overview

Therasis, Inc. is a drug discovery company that develops oncology therapeutics for use as single agents and in combination therapy. It offers Therasis Filter, which enables the identification of disease-specific alterations in networks of molecular interactions that regulate cellular processes. The company was incorporated in 2007 and is based in New York, New York.

462 First Avenue

Suite 908

New York, NY 10016

United States

Founded in 2007

Phone:

212-823-2019

Key Executives for Therasis, Inc.

Co-Founder and Director
Age: 62
Co-Founder and Director
Co-Founder and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Iluminage Beauty United States
Lightyear Technology, Inc. United States
Capintec, Inc. United States
Enspire Group LLC United States
AktiVax Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Therasis, Inc., please visit www.therasis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.